GlassScriptPhysician profile
Melissa Aldridge
NPI 1073132429
$2,000.37
in general payments reported to CMS, 2019-2025
14 companies · $841 in 2025
The $841 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $126 · 2024: $1,033 · 2025: $841.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,921 · Education: $78.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,921.38 |
| Education | $78.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $475.68 | 2023-2025 | |
| Actelion Pharmaceuticals US, INC. | $365.22 | 2023-2025 | Uptravi, Opsumit |
| United Therapeutics Corporation | $206.52 | 2024-2025 | Tyvaso, Tyvaso |
| Regeneron Healthcare Solutions, INC. | $203.18 | 2024-2025 | Dupixent |
| Boehringer Ingelheim Pharmaceuticals, INC. | $178.65 | 2024-2025 | Ofev, Stiolto Respimat, Spiriva Respimat |
| Merck Sharp & Dohme LLC | $175.23 | 2023-2025 | Winrevair, Zerbaxa, Recarbrio |
| Astrazeneca Pharmaceuticals LP | $146.76 | 2023-2025 | Fasenra, Tezspire |
| Abiomed | $72.68 | 2023-2024 | Impella |
| Mallinckrodt Hospital Products INC. | $38.95 | 2024 | Acthar |
| Philips North America LLC | $30.58 | 2024-2025 | (Ak6) Vest Therapy, Vest Therapy Und |
| Theratechnologies INC. | $30.38 | 2025 | Egrifta, Trogarzo |
| Bayer Healthcare Pharmaceuticals INC. | $29.95 | 2024 | |
| Mylan Specialty L.P. | $26.52 | 2024 | Yupelri |
| Viatris Specialty LLC | $20.07 | 2025 | Yupelri |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melissa Aldridge listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.